1. Home
  2. CTMX vs TMQ Comparison

CTMX vs TMQ Comparison

Compare CTMX & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTMX
  • TMQ
  • Stock Information
  • Founded
  • CTMX 2008
  • TMQ 2004
  • Country
  • CTMX United States
  • TMQ Canada
  • Employees
  • CTMX N/A
  • TMQ N/A
  • Industry
  • CTMX Biotechnology: Pharmaceutical Preparations
  • TMQ Precious Metals
  • Sector
  • CTMX Health Care
  • TMQ Basic Materials
  • Exchange
  • CTMX Nasdaq
  • TMQ Nasdaq
  • Market Cap
  • CTMX 85.3M
  • TMQ 83.6M
  • IPO Year
  • CTMX 2015
  • TMQ N/A
  • Fundamental
  • Price
  • CTMX $0.90
  • TMQ $1.32
  • Analyst Decision
  • CTMX Buy
  • TMQ
  • Analyst Count
  • CTMX 6
  • TMQ 0
  • Target Price
  • CTMX $5.77
  • TMQ N/A
  • AVG Volume (30 Days)
  • CTMX 963.1K
  • TMQ 330.0K
  • Earning Date
  • CTMX 03-10-2025
  • TMQ 04-02-2025
  • Dividend Yield
  • CTMX N/A
  • TMQ N/A
  • EPS Growth
  • CTMX N/A
  • TMQ N/A
  • EPS
  • CTMX 0.16
  • TMQ N/A
  • Revenue
  • CTMX $126,617,000.00
  • TMQ N/A
  • Revenue This Year
  • CTMX $22.55
  • TMQ N/A
  • Revenue Next Year
  • CTMX N/A
  • TMQ N/A
  • P/E Ratio
  • CTMX $5.81
  • TMQ N/A
  • Revenue Growth
  • CTMX 33.66
  • TMQ N/A
  • 52 Week Low
  • CTMX $0.79
  • TMQ $0.25
  • 52 Week High
  • CTMX $5.85
  • TMQ $1.48
  • Technical
  • Relative Strength Index (RSI)
  • CTMX 43.26
  • TMQ 59.06
  • Support Level
  • CTMX $0.82
  • TMQ $1.22
  • Resistance Level
  • CTMX $0.92
  • TMQ $1.38
  • Average True Range (ATR)
  • CTMX 0.06
  • TMQ 0.10
  • MACD
  • CTMX 0.00
  • TMQ 0.00
  • Stochastic Oscillator
  • CTMX 51.32
  • TMQ 63.16

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-lead-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: